These include but are not limited to full reassembly of pharmaceutical packages, assembly from bulk, over-labeling of packages, leaflet replacement and addition of anti-tampering device and overprinting of details on the outer pack. For packs that cannot be opened because of the anti-tampering device to meet FMD requirements, CPL has pioneered a novel over-labelling process where the translation of the product leaflet and outer carton details are affixed on the outside of the carton with adhesive film which is perforated on one side to allow the leaflet to be opened by the patient and yet the leaflet remains attached to one side of the carton.